肿瘤负荷而非对比增强与儿童及青少年视路胶质瘤的视觉功能相关——一项回顾性磁共振成像研究
该回顾性MRI研究在35例视路胶质瘤患者(63%为NF1相关)的298次MRI上测量肿瘤负荷并对增强进行半定量评分,分析其与视力(LogMAR)的关系。结果显示NF1相关视路胶质瘤中视神经宽度与视力强相关(回归系数0.75;CI 0.61-0.88),而与增强弱相关(0.06;-0.04-0.15);散发性视路胶质瘤中肿瘤体积和视神经宽度较增强更为相关。作者认为肿瘤负荷测量可能比增强对监测更有意义,并质疑这些患者常规使用对比剂。
要点
- NF1相关视路胶质瘤中视神经宽度与视力强相关(回归系数0.75;CI 0.61-0.88),与增强弱相关(0.06;-0.04-0.15)。
- 散发性视路胶质瘤中肿瘤体积和视神经宽度较增强与视力更相关。
- 作者认为肿瘤负荷测量可能比增强对监测更有意义,并质疑常规使用对比剂。
核心结论
- 鉴于视力是相关结局指标,肿瘤负荷测量对视路胶质瘤的监测可能比增强更有意义;因此应质疑这些患者常规使用对比剂。
研究设计与样本
- 回顾性研究,共纳入35例视路胶质瘤患者(63%为NF1相关),分析298次MRI。
- 肿瘤负荷回顾性测量,增强采用半定量评分;计算肿瘤负荷与增强的Spearman秩相关,并使用线性混合模型检验肿瘤负荷和增强对相应视力测试(LogMAR)的影响。
主要发现
- NF1相关视路胶质瘤中,视神经宽度与视力强相关(回归系数0.75;置信区间0.61-0.88),而与增强弱相关(0.06;-0.04-0.15)。
- 散发性视路胶质瘤中,肿瘤体积和视神经宽度与视力更相关(分别为0.31;-0.19-0.81和0.39;0.05-0.73),增强的相关性为(0.09;-0.09-0.27)。
临床怎么用
- 作者认为肿瘤负荷测量可能比增强对监测更有意义,并质疑这些患者常规使用对比剂。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Optic pathway gliomas are often asymptomatic tumors occurring in children with neurofibromatosis type 1 (NF1 + OPG) or sporadically (spOPG). Treatment is usually prompted by visual loss and/or tumor progression on MRI. The aim of this study was to investigate the relationship between visual acuity (VA), tumor growth, and contrast enhancement to provide more distinct indications for the administration of gadolinium-based contrast agents. METHODS: Tumor load was retrospectively measured and enhancement semi-quantitatively scored on 298 MRIs of 35 patients (63% NF1 + OPG). Spearman rank correlation between tumor load and enhancement was calculated and a linear mixed model used to examine the influence of tumor load and enhancement on corresponding VA tests (LogMAR). RESULTS: The optic nerve width in NF1 + OPGs was strongly associated with VA (regression coefficient 0.75; confidence interval 0.61-0.88), but weakly with enhancement (0.06; -0.04-0.15). In spOPGs, tumor volume and optic nerve width were more relevant (0.31; -0.19-0.81 and 0.39; 0.05-0.73) than enhancement (0.09; -0.09-0.27). CONCLUSIONS: Tumor load measures may be more relevant for the surveillance of optic pathway gliomas than enhancement, given that VA is the relevant outcome parameter. Regular contrast administration should therefore be questioned in these patients.
引用
- Kilian A, Aigner A, Simon M, et al. Tumor load rather than contrast enhancement is associated with the visual function of children and adolescents with optic pathway glioma - a retrospective Magnetic Resonance Imaging study. J Neurooncol. 2022. PMID: 34994964. doi:10.1007/s11060-021-03941-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。